142 related articles for article (PubMed ID: 34039652)
1. Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade.
Daugan MV; Revel M; Thouenon R; Dragon-Durey MA; Robe-Rybkine T; Torset C; Merle NS; Noé R; Verkarre V; Oudard SM; Mejean A; Validire P; Cathelineau X; Sanchez-Salas R; Pickering MC; Cremer I; Mansuet-Lupo A; Alifano M; Sautès-Fridman C; Damotte D; Fridman WH; Roumenina LT
Cancer Immunol Res; 2021 Aug; 9(8):909-925. PubMed ID: 34039652
[TBL] [Abstract][Full Text] [Related]
2. Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s.
Daugan MV; Revel M; Russick J; Dragon-Durey MA; Gaboriaud C; Robe-Rybkine T; Poillerat V; Grunenwald A; Lacroix G; Bougouin A; Meylan M; Verkarre V; Oudard SM; Mejean A; Vano YA; Perkins G; Validire P; Cathelineau X; Sanchez-Salas R; Damotte D; Fremeaux-Bacchi V; Cremer I; Sautès-Fridman C; Fridman WH; Roumenina LT
Cancer Immunol Res; 2021 Aug; 9(8):891-908. PubMed ID: 34039653
[TBL] [Abstract][Full Text] [Related]
3. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
[TBL] [Abstract][Full Text] [Related]
4. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
[TBL] [Abstract][Full Text] [Related]
5. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
Merinero HM; García SP; García-Fernández J; Arjona E; Tortajada A; Rodríguez de Córdoba S
Kidney Int; 2018 Feb; 93(2):470-481. PubMed ID: 28941939
[TBL] [Abstract][Full Text] [Related]
6. Complement factor H contributes to mortality in humans and mice with bacterial meningitis.
Kasanmoentalib ES; Valls Serón M; Engelen-Lee JY; Tanck MW; Pouw RB; van Mierlo G; Wouters D; Pickering MC; van der Ende A; Kuijpers TW; Brouwer MC; van de Beek D
J Neuroinflammation; 2019 Dec; 16(1):279. PubMed ID: 31883521
[TBL] [Abstract][Full Text] [Related]
7. Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage.
Nagamachi S; Ohsawa I; Suzuki H; Sato N; Inoshita H; Hisada A; Honda D; Shimamoto M; Shimizu Y; Horikoshi S; Tomino Y
BMC Nephrol; 2014 May; 15():82. PubMed ID: 24885016
[TBL] [Abstract][Full Text] [Related]
8. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.
Heurich M; Martínez-Barricarte R; Francis NJ; Roberts DL; Rodríguez de Córdoba S; Morgan BP; Harris CL
Proc Natl Acad Sci U S A; 2011 May; 108(21):8761-6. PubMed ID: 21555552
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants.
Dekkers G; Brouwer MC; Jeremiasse J; Kamp A; Biggs RM; van Mierlo G; Lauder S; Katti S; Kuijpers TW; Rispens T; Jongerius I
J Immunol; 2020 Oct; 205(7):1778-1786. PubMed ID: 32848031
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of FH Protection Against Neovascular AMD.
Borras C; Delaunay K; Slaoui Y; Abache T; Jorieux S; Naud MC; Sanharawi ME; Gelize E; Lassiaz P; An N; Kowalczuk L; Ayassami C; Moulin A; Behar-Cohen F; Mascarelli F; Dinet V
Front Immunol; 2020; 11():443. PubMed ID: 32318056
[TBL] [Abstract][Full Text] [Related]
11. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
Roumenina LT; Daugan MV; Noé R; Petitprez F; Vano YA; Sanchez-Salas R; Becht E; Meilleroux J; Clec'h BL; Giraldo NA; Merle NS; Sun CM; Verkarre V; Validire P; Selves J; Lacroix L; Delfour O; Vandenberghe I; Thuilliez C; Keddani S; Sakhi IB; Barret E; Ferré P; Corvaïa N; Passioukov A; Chetaille E; Botto M; de Reynies A; Oudard SM; Mejean A; Cathelineau X; Sautès-Fridman C; Fridman WH
Cancer Immunol Res; 2019 Jul; 7(7):1091-1105. PubMed ID: 31164356
[TBL] [Abstract][Full Text] [Related]
12. Complement Factor H Family Proteins Modulate Monocyte and Neutrophil Granulocyte Functions.
Kárpáti É; Kremlitzka M; Sándor N; Hajnal D; Schneider AE; Józsi M
Front Immunol; 2021; 12():660852. PubMed ID: 34671340
[TBL] [Abstract][Full Text] [Related]
13. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
[TBL] [Abstract][Full Text] [Related]
14. Hijacking Factor H for Complement Immune Evasion.
Moore SR; Menon SS; Cortes C; Ferreira VP
Front Immunol; 2021; 12():602277. PubMed ID: 33717083
[TBL] [Abstract][Full Text] [Related]
15. The possible role of factor H in colon cancer resistance to complement attack.
Wilczek E; Rzepko R; Nowis D; Legat M; Golab J; Glab M; Gorlewicz A; Konopacki F; Mazurkiewicz M; Sladowski D; Gornicka B; Wasiutynski A; Wilczynski GM
Int J Cancer; 2008 May; 122(9):2030-7. PubMed ID: 18183578
[TBL] [Abstract][Full Text] [Related]
16. Noncanonical Functions of C1s Complement Its Canonical Functions in Renal Cancer.
Magrini E; Garlanda C
Cancer Immunol Res; 2021 Aug; 9(8):855. PubMed ID: 34158282
[TBL] [Abstract][Full Text] [Related]
17. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera.
Pouw RB; Brouwer MC; de Gast M; van Beek AE; van den Heuvel LP; Schmidt CQ; van der Ende A; Sánchez-Corral P; Kuijpers TW; Wouters D
Blood Adv; 2019 Feb; 3(4):621-632. PubMed ID: 30804016
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
[TBL] [Abstract][Full Text] [Related]
20. Local complement factor H protects kidney endothelial cell structure and function.
Mahajan S; Jacob A; Kelkar A; Chang A; Mcskimming D; Neelamegham S; Quigg RJ; Alexander JJ
Kidney Int; 2021 Oct; 100(4):824-836. PubMed ID: 34139209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
